Literature DB >> 843950

Studies on the relationship of binding affinity to psychoactive and anticholingergic potency of a group of psychotomimetic glycolates.

J Baumgold, L G Abood, R Aronstam.   

Abstract

A study was undertaken of the possible relationship of the binding affinity of a series of anticholinergic psychotomimetic drugs to their psychopharmacological and anticholinergic effects. Binding was measured to brain homogenates and nerve endings using [3H]quinuclidinyl benzilate (QB), a highly potent psychotomimetic agent presumably affecting muscarinic sites in the brain. The two stereoisomers of QB were compared; and although the L-isomer had 15 times the binding affinity of D-isomer, the L-isomer had over 200 times the psychopharmacological potency of the D-form. When the relative binding affinity of a homologous series of glycolate esters was compared with their relative psychoacitve potency, the correlation was excellent; however, when compounds with heterocyclic amino rings (e.g., tropanol) other than quinuclidine and piperidine were considered, the correlation was poor. The correlation between binding affinity and antagonism to acetylcholine-induced contraction of ileum was more consistent. A study was undertaken on the effect of added lipids on QB binding to nerve endings, and it was found that phosphatidyl serine had a significant enhancing effect while gangliosides were inhibitory.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843950     DOI: 10.1016/0006-8993(77)90889-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Stereospecific 3H-QNB binding to human erythrocyte membranes associated with muscarinic cholinergic receptors.

Authors:  B Bering; W E Müller
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

2.  Effects of 3-quinuclidinyl benzilate on fixed-ratio responding and open field behavior in the rat.

Authors:  W F Liu; N W Hu; T F Chien; J M Beaton
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.